Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $8.28 in the prior trading day, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) closed at $8.36, up 0.97%. In other words, the price has increased by $0.97 from its previous closing price. On the day, 3.42 million shares were traded.
Ratios:
Our goal is to gain a better understanding of BCRX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.58 and its Current Ratio is at 2.63.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on February 25, 2025, initiated with a Outperform rating and assigned the stock a target price of $15.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on September 18, 2023, whereas the target price for the stock was revised from $9 to $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 ’24 when Hutson Nancy J sold 7,000 shares for $7.54 per share. The transaction valued at 52,780 led to the insider holds 86,638 shares of the business.
Hutson Nancy J bought 7,000 shares of BCRX for $52,584 on Dec 13 ’24. On Jun 24 ’24, another insider, McKee Amy E, who serves as the Director of the company, sold 8,600 shares for $6.32 each. As a result, the insider received 54,352 and left with 27,831 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.84.
Stock Price History:
Over the past 52 weeks, BCRX has reached a high of $9.50, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is 4.23%, while the 200-Day Moving Average is calculated to be 11.97%.
Shares Statistics:
A total of 208.54M shares are outstanding, with a floating share count of 195.41M. Insiders hold about 5.66% of the company’s shares, while institutions hold 79.17% stake in the company.
